NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹102 Cr | ₹198 Cr | ₹161 Cr | ₹76 Cr | ₹89 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹198 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹89 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹102 Cr | -48.56 | |
| Mar2024 | ₹198 Cr | 22.75 | |
| Mar2023 | ₹161 Cr | 113.41 | |
| Mar2022 | ₹76 Cr | -15.46 | |
| Mar2021 | ₹89 Cr | - | |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹284.8 Cr | 1.2% | -34.3% | -64.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 1.2% |
-34.3% |
-64.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses